Profile data is unavailable for this security.
About the company
Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products.
- Revenue in ILS (TTM)6.19m
- Net income in ILS-58.57m
- Incorporated2014
- Employees76.00
- LocationPulsenmore LtdOmarim St 8OMER 8496500IsraelISR
- Fax+972 886900466
- Websitehttps://pulsenmore.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endymed Ltd | 84.46m | 2.05m | 40.53m | 46.00 | 19.30 | 0.7158 | 10.94 | 0.48 | 0.1526 | 0.1526 | 6.20 | 4.11 | 1.13 | 2.46 | 18.63 | 1,835,987.00 | 2.75 | 10.38 | 3.38 | 13.32 | 51.20 | 51.92 | 2.43 | 8.91 | 3.02 | -- | 0.0771 | -- | 6.77 | 4.30 | -34.94 | -22.83 | -15.24 | -- |
| Epitomee Medical Ltd | 37.08m | -21.07m | 101.00m | 42.00 | -- | 0.7827 | -- | 2.72 | -0.7116 | -0.7116 | 1.25 | 4.34 | 0.2095 | -- | 35.21 | 882,761.90 | -11.90 | -- | -12.44 | -- | -- | -- | -56.82 | -- | -- | -- | 0.1021 | -- | -- | -- | 63.08 | -- | -- | -- |
| Nissan Medical Industries Ltd. | 733.91m | 5.65m | 142.52m | 395.00 | 26.54 | 0.6232 | 2.84 | 0.1942 | 0.5911 | 0.5911 | 79.17 | 25.18 | 1.02 | 5.40 | 6.92 | 1,858,010.00 | 2.64 | 4.12 | 5.01 | 7.71 | 18.50 | 18.76 | 2.59 | 4.32 | 0.6375 | 1.83 | 0.3585 | -- | 7.20 | 2.20 | 115.67 | -25.79 | -3.21 | -- |
| Pulsenmore Ltd | 6.19m | -58.57m | 175.17m | 76.00 | -- | 1.32 | -- | 28.31 | -1.14 | -1.14 | 0.1208 | 2.64 | 0.0297 | 0.2102 | 2.26 | 81,421.05 | -28.14 | -- | -30.33 | -- | 35.57 | -- | -946.46 | -- | 10.00 | -19.48 | 0.1734 | -- | -42.78 | -- | -164.78 | -- | -- | -- |
| Bonus Biogroup Ltd | 0.00 | -28.53m | 197.38m | 58.00 | -- | 6.74 | -- | -- | -0.064 | -0.064 | 0.00 | 0.0251 | 0.00 | -- | -- | 0.00 | -47.75 | -76.10 | -53.85 | -97.19 | -- | -- | -- | -- | -- | -- | 0.2758 | -- | -- | -- | 26.29 | -- | 19.30 | -- |
| Elron Ventures Ltd | 17.53m | -30.31m | 264.65m | 8.00 | -- | 0.5466 | -- | 15.10 | -0.6083 | -0.6083 | 0.3507 | 9.18 | 0.0287 | -- | 0.3217 | -- | -6.67 | 1.60 | -7.64 | 2.05 | 73.33 | -- | -232.47 | 70.60 | -- | -0.1005 | 0.067 | 227.98 | -25.89 | 27.74 | -111.76 | -- | -44.01 | -- |
| Brainsway Ltd | 117.85m | -15.56m | 364.41m | 134.00 | -- | 2.36 | -- | 3.09 | -0.47 | -0.47 | 3.58 | 4.64 | 0.4988 | 2.20 | 7.37 | -- | -6.59 | -15.50 | -7.66 | -18.35 | 73.86 | 75.91 | -13.20 | -29.69 | 5.30 | -- | -- | -- | 16.96 | 14.15 | 68.56 | -- | 3.89 | -- |
| InterCure Ltd | 355.55m | -61.96m | 509.05m | 270.00 | -- | 1.12 | 155.72 | 1.43 | -1.36 | -1.36 | 7.72 | 9.99 | 0.4076 | 2.19 | 2.12 | 1,316,863.00 | -7.28 | -2.03 | -10.73 | -2.81 | 30.47 | 38.07 | -17.87 | -5.24 | 1.39 | -1.60 | 0.2948 | -- | -8.52 | -- | -238.24 | -- | 94.95 | -- |
| Sofwave Medical Ltd | 196.84m | -20.11m | 570.60m | -- | -- | 6.01 | -- | 2.90 | -0.5887 | -0.5887 | 5.76 | 2.77 | 1.23 | 2.76 | 6.50 | -- | -12.60 | -- | -19.03 | -- | 74.82 | -- | -10.22 | -- | 2.20 | -30.45 | 0.0455 | -- | 41.22 | -- | 57.61 | -- | -- | -- |
| Ilex Medical Ltd | 930.89m | 50.89m | 730.25m | 223.00 | 14.35 | 1.17 | 7.41 | 0.7845 | 4.55 | 4.55 | 83.19 | 55.73 | 0.9721 | 4.58 | 3.48 | 4,174,395.00 | 5.31 | 13.84 | 7.21 | 20.89 | 24.91 | 31.08 | 5.47 | 12.17 | 1.89 | 18.83 | 0.0719 | 29.51 | 6.69 | 9.14 | -50.17 | 1.61 | 16.32 | -11.34 |
| Holder | Shares | % Held |
|---|---|---|
| Adar Capital Partners Ltd.as of 30 Jun 2023 | 2.71m | 5.41% |
| Yelin Lapidot Mutual Fund Management Ltd.as of 29 Feb 2024 | 477.10k | 0.95% |
| Meitav Mutual Funds Ltd.as of 29 Feb 2024 | 46.82k | 0.09% |
| Modelim Money Markets Ltd.as of 29 Feb 2024 | 35.00k | 0.07% |
| KSM Mutual Funds Ltd.as of 29 Feb 2024 | 29.73k | 0.06% |
| Barometer Investment House Ltd.as of 31 Jan 2024 | 21.86k | 0.04% |
| Migdal Mutual Funds Ltd.as of 29 Feb 2024 | 18.37k | 0.04% |
| Alumot Sprint Mutual Funds Management Ltd.as of 28 Dec 2023 | 4.17k | 0.01% |
| Psagot Mutual Funds Ltd.as of 29 Feb 2024 | 3.52k | 0.01% |
| Harel Mutual Funds Ltd.as of 29 Feb 2024 | 1.21k | 0.00% |
